Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,333 public trials 1,978 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

NCT04641247

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Whittier, California, United States
View all 25 locations
View Trial Details
Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

NCT07046923

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +28 more
Locations
  • Stanford Medicine Cancer Center Stanford, California, United States
  • Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute Orlando, Florida, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • The University of Chicago Medical Center (UCMC) Chicago, Illinois, United States
View all 27 locations
View Trial Details
Recruiting

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

NCT05005403

Conditions
Anophthalmia with pulmonary hypoplasia, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • City of Hope National Medical Center /ID# 276272 Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 278589 Irvine, California, United States
  • USC Norris Comprehensive Cancer Center /ID# 279603 Los Angeles, California, United States
  • University of Illinois Hospital and Health Sciences System /ID# 251750 Chicago, Illinois, United States
View all 48 locations
View Trial Details
Recruiting

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

NCT06930859

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Novartis Investigative Site Kaluga, Russia
  • Novartis Investigative Site Pskov, Russia
  • Novartis Investigative Site Ryazan, Russia
  • Novartis Investigative Site Saint Petersburg, Russia
View all 40 locations
View Trial Details

Related conditions